1Di Cristofano A, Pesee B. Cordon C,et al. PTEN is essential for embryonic development and tumor suppression. Nat Genet, 1998, 19:348-355.
2Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet, 1997 ,15(4) :356-362.
3Tamura M, Gu J, Yamada KM, et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science, 1998,280 : 1614- 1617.
4Davies MA. Regulation of Akt/PKB activity, cellular growth,and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res, 1999,159(11) : 2551- 2556.
5Tian XX, Pang JC, To ss, et al. Restoration of wild-type PTEN expression leads to apoptosis, induces differentiation, and reduces telomerase activity in human glioma cells. J Neutopathol Exp Neuropathol Exp Neurol, 1999,58 : 472 - 479.
6Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1 dephosphoralates the lipid second messenger, phosphatidylinositol 3,4,5-triophosphaphate. J Boil Chem, 1998,273 : 13375 - 13378.
7Kondo Ki, Yao M, Kobayashi K, et al. PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines. Int J Cancer. 2001,91 : 219- 224.
8Bose S,Wang SI,Terry MB,et al. Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas. Oncogene, 1998,17 : 123- 127.
9Stambolic V, Suzuki A. Pompa JL, et al. Negative regulation of PKB/Akt dependent cell survival by the tumor suppressor PTEN. Cell, 1998,95 : 29 -39.
